shopify analytics ecommerce tracking
Chinese Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Novo Nordisk – major shareholder announcement

Read more ››
By: GlobenewsWire - 14 Mar 2022

WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics

Read more ››
By: PR Newswire Association LLC. - 14 Mar 2022
Related companies:  Wuxi Biologics (Cayman) Inc.

MediLink Therapeutics closes US$70 million Series B financing

Read more ››
By: PR Newswire Association LLC. - 14 Mar 2022
Related companies:  Medilink West Midlands | Medilink UK | MEDILINK PHARMACHEM | Suzhou Medilink Therapeutics Co., Ltd.

Hexvix® Has Obtained CDE Approval for the Inclusion In the Clinical Real-world Evidence Pilot Study

Read more ››
By: PR Newswire Association LLC. - 14 Mar 2022
Related companies:  Asieris Pharmaceuticals

Digital Medicine Society Rallies Global Healthcare Leaders to Collaborate on Digital Measurement for Alzheimer's Disease

<legend role="h2">Collaboration marks an ambitious step toward advancing therapies for Alzheimer's disease and related dementias</legend> Read more ››
By: PR Newswire Association LLC. - 14 Mar 2022

Impact Therapeutics Announces Completion of Series D1 Financing

Read more ››
By: PR Newswire Association LLC. - 14 Mar 2022
Related companies:  IMPACT Therapeutics, Inc.

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

Deal signals Company's latest efforts to further enhance its international commercial footprint Read more ››
By: PR Newswire Association LLC. - 14 Mar 2022
Related companies:  Everest Medicines (Shanghai)

CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer

Read more ››
By: PR Newswire Association LLC. - 14 Mar 2022
Related companies:  CStone Pharmaceuticals

Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacity to 530 Million Tablets Per Year

Read more ››
By: PR Newswire Association LLC. - 13 Mar 2022
Related companies:  Ascletis Pharma Inc.

AnPac Bio-Medical Sciences Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

Read more ››
By: GlobenewsWire - 11 Mar 2022
Related companies:  Anpac Technology USA (Anpac Bio) | AnPac Bio-Medical Science Co., Ltd.

LianBio Issues Statement Regarding the HFCAA

Read more ››
By: GlobenewsWire - 11 Mar 2022
Related companies:  LianBio

Gracell Biotechnologies to Participate in Oppenheimer 32nd Annual Healthcare Conference

Read more ››
By: GlobenewsWire - 10 Mar 2022
Related companies:  Gracell Biotechnology Ltd.

Mustang Bio to Participate in Three March 2022 Investor Conferences

Read more ››
By: GlobenewsWire - 10 Mar 2022
Related companies:  Mustang Investment Consulting (Shanghai) Co., Ltd. | Mustang Bio

Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families

Read more ››
By: PR Newswire Association LLC. - 10 Mar 2022
Related companies:  Fosun International Limited | Fosun Pharmaceutical AG | Fosun Pharma USA Inc. | Fosun Kite Biotechnology Co., Ltd.

Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial

Read more ››
By: PR Newswire Association LLC. - 10 Mar 2022
Related companies:  Everest Medicines (Shanghai)

Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 10 Mar 2022

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

Read more ››
By: PR Newswire Association LLC. - 10 Mar 2022
Related companies:  Antengene Corporation

Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022

Read more ››
By: GlobenewsWire - 09 Mar 2022
Related companies:  Mustang Investment Consulting (Shanghai) Co., Ltd. | Mustang Bio

Sharp celebrates 100 million product units sold worldwide equipped with Plasmacluster Ion technology

Read more ››
By: PR Newswire Association LLC. - 09 Mar 2022

Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma

Read more ››
By: PR Newswire Association LLC. - 09 Mar 2022
Related companies:  Antengene Corporation
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of China (Mainland)?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • May 2022
    • Pharma-Biotech Product & Company Valuation with Dr. P Frei
  • June 2022
    • Digital RESI
    • Product & Company Valuation Course
See Events »
Add an Event »

Latest company news

United Health Products Provides Regulatory Update
18 May 2022 (GlobenewsWire)

Antengene Announces XPOVIO® Treatment Regimens Included for the First Time in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China
18 May 2022 (PR Newswire Association LLC.)

SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China
18 May 2022 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The Chinese Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com